AOD-9604 vs 5-Amino-1MQ is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
AOD-9604 and 5-Amino-1MQ are both popular research peptides that work through different mechanisms. AOD-9604 is a Lipolytic peptide, GH fragment analog focused on fat loss, while 5-Amino-1MQ is a Small molecule NNMT inhibitor targeting fat oxidation.
What Are AOD-9604 and 5-Amino-1MQ?
AOD-9604 (Fragment 177-191 of Human Growth Hormone (modified)) is a Lipolytic peptide, GH fragment analog. Synthetic analog of human GH fragment 177-191, engineered to selectively activate lipolysis without systemic GH effects. It is researched for fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation.
5-Amino-1MQ (5-Amino-1-Methyl-Quinolinium) is a Small molecule NNMT inhibitor. Synthetic compound designed to inhibit nicotinamide N-methyltransferase (NNMT) and boost NAD+ synthesis through the salvage pathway. It is researched for fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects.
While both are popular research peptides, they work through fundamentally different mechanisms and serve different primary purposes.
How Do AOD-9604 and 5-Amino-1MQ Work Differently?
AOD-9604 mechanism: Activates beta-3 adrenergic receptors in adipose tissue, triggering cAMP-mediated lipolysis and release of stored fat for energy. Suppresses lipogenesis (new fat formation) while promoting fat breakdown. Unlike full growth hormone, it does not raise IGF-1 or impact glucose metabolism, blood sugar, or insulin sensitivity.
5-Amino-1MQ mechanism: Selectively inhibits the NNMT enzyme, which normally degrades nicotinamide and prevents NAD+ synthesis. By blocking NNMT, it frees nicotinamide for NAD+ production via the salvage pathway and activates SIRT1 longevity pathways. Also stimulates AMP-activated protein kinase (AMPK) in adipocytes and myocytes, promoting mitochondrial biogenesis and fat oxidation.
These distinct mechanisms are why the two peptides are often used for different research goals — or combined to target multiple pathways.
How Do the Dosing Protocols Compare?
AOD-9604: 250-1000 mcg daily administered once daily, ideally morning fasted via subcutaneous injection. Half-life: not established. Cycle: 12-24 weeks.
5-Amino-1MQ: 150-500 mcg subcutaneous, 50-100 mg oral administered once to twice daily via subcutaneous injection or oral. Half-life: not established in humans. Cycle: 4-12 weeks.
Use our peptide calculator for reconstitution math for either compound.
How Do the Benefits Compare?
AOD-9604 benefits: fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation.
5-Amino-1MQ benefits: fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects.
The overlap in benefits determines whether these peptides compete for the same use case or complement each other in a stack.
How Do the Side Effects Compare?
AOD-9604: Well-tolerated across 900+ participants in clinical trials. Minimal adverse effects — potential mild headache, dizziness, or injection site reactions. One of the safest peptides in terms of documented human tolerability.
5-Amino-1MQ: Good tolerability in preclinical data. No major adverse events reported. Limited human safety data — long-term effects in humans unknown.
Can You Stack AOD-9604 and 5-Amino-1MQ Together?
Many researchers combine AOD-9604 and 5-Amino-1MQ in stacking protocols. The different mechanisms mean they can potentially provide complementary effects without competing for the same receptors.
Pairs with CJC-1295/Ipamorelin for enhanced body composition (AOD handles fat loss while GH peptides handle lean mass). Also complements fasting and HIIT training protocols. See our stacking guide for general principles.
Which Is Better: AOD-9604 or 5-Amino-1MQ?
There is no universal answer. AOD-9604 may be preferable for researchers focused on fat loss, while 5-Amino-1MQ is stronger for fat oxidation.
For the most comprehensive results, many researchers combine both. Review each compound's individual guide for detailed protocols: AOD-9604 | 5-Amino-1MQ.
Complete Guide
AOD-9604: The Fat Loss Peptide Fragment
Research-Grade Sourcing
If you're going to research AOD-9604 vs 5-Amino-1MQ, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is AOD-9604 vs 5-Amino-1MQ?
AOD-9604 vs 5-Amino-1MQ (AOD-9604 vs 5-Amino-1MQ) is a research peptide. Synthetic peptide. It is researched for various applications.
What is the recommended AOD-9604 vs 5-Amino-1MQ dosage?
Common dosages: varies administered per protocol via subcutaneous injection. Cycle length: 4-12 weeks. Half-life: varies. Use our peptide calculator for exact reconstitution math.
What are the side effects of AOD-9604 vs 5-Amino-1MQ?
Limited safety data available. Potential injection site reactions and individual sensitivity. No serious adverse events documented in available literature.
Is AOD-9604 vs 5-Amino-1MQ safe?
AOD-9604 vs 5-Amino-1MQ has shown a preliminary safety profile in research. Not FDA-approved. Available as a research chemical in most jurisdictions. All research should follow appropriate safety protocols.